胶质瘤中叉头框蛋白N2与F2的表达及意义

张佳; 罗潇潇; 郭忻然; 吴锋; 郑兰荣

doi:10.16098/j.issn.0529-1356.2022.02.004

PDF(6812 KB)

解剖学报 ›› 2022, Vol. 53 ›› Issue (2) : 160-165. DOI: 10.16098/j.issn.0529-1356.2022.02.004

神经生物学

胶质瘤中叉头框蛋白N2与F2的表达及意义

张佳^1,2 罗潇潇^1,2 郭忻然^1,2 吴锋³ 郑兰荣^1,2,4*

作者信息 +

Expression and significance of fork head box protein N2 and F2 in gliomas

ZHANG Jia^1,2 LUO Xiao-xiao^1,2 GUO Xin-ran^1,2 WU Feng³ ZHENG Lan-rong^1,2,4*

Author information +

文章历史 +

摘要

目的观察叉头框蛋白N2（FOXN2）与叉头框蛋白F2（FOXF2）在正常脑组织和各级别胶质瘤中的表达情况，探讨两者与胶质瘤级别的关系，推测其在胶质瘤发生发展中的作用，为胶质瘤的治疗寻找可能的药物治疗靶点。方法从皖南医学院弋矶山医院病理科调取36例2016年1月～2020年12月脑胶质瘤患者手术切除的胶质瘤组织标本，双盲法进行免疫组织化学和免疫荧光染色检测FOXN2、FOXF2的表达情况；采用SPSS 18.0统计学软件进行分析，以P<0.05为差异有统计学意义。再对2020年1月～2021年1月皖南医学院弋矶山医院神经外科手术中获取的新鲜正常脑组织、低级别胶质瘤组织和高级别胶质瘤组织进行Western blotting、Real-time PCR实验（正常脑组织均来自外伤手术患者）。结果免疫组织化学与免疫荧光结果表明，胶质瘤级别越高FOXN2与FOXF2的表达越低（P<0.05）；Western blotting实验显示，正常脑组织及低级别胶质瘤中FOXN2和FOXF2表达都高于高级别胶质瘤组（P<0.05）；Realtime PCR结果显示，正常脑组织中FOXN2和FOXF2的表达同样高于高级别胶质瘤组（P<0.01）。结论 FOXN2和FOXF2在正常脑组织中有表达，在胶质瘤中低表达且呈级别依赖性，提示FOXN2和FOXF2与胶质瘤的级别及不良预后有关，增强FOXN2和FOXF2的表达有望成为胶质瘤治疗的靶点。

Abstract

Objective To observe the expression levels of fork head box protein N2 (FOXN2) and fork head box protein F2 (FOXF2) in normal brain tissue, low-grade glioma and high-grade glioma, and to explore the relationship between the two and the grade of glioma, and then deduce their roles in the occurrence and development of glioma, to look for possibilities target of drug therapy. Methods From January 2016 to December 2020, 36 glioma specimens were collected from the Department of Pathology, Yijishan Hospital, Wannan Medical College. The expressions of FOXN2 and FOXF2 were detected by immunohistochemistry and immunofluorescence with the double-blind method , and analyzed by SPSS18.0 software, with a statistical significance of P<0.05. Then Western blotting and Real-time PCR experiments were carried out on fresh normal brain tissues, low-grade glioma tissues, high-grade glioma tissues during neurosurgery in Yijishan Hospital of Wannan Medical College from January 2020 to January 2021 (normal brain tissues were all trauma patients). Results The results of immunohistochemistry and immunofluorescence showed that the higher grade of glioma, the lower expressions of FOXN2 and FOXF2 would be (P<0.05). Western blotting showed that the expressions of FOXN2 and FOXF2 in normal brain tissue and low-grade glioma were higher than those in high-grade glioma (P<0.05). The result of Real-time PCR showed that the expressions of FOXN2 and FOXF2 in normal brain tissue were higher than those in high-grade glioma (P<0.01). Conclusion FOXN2 and FOXF2 are expressed in normal brain tissues, and their expression is low in glioma in a grade-dependent manner, suggesting that FOXN2 and FOXF2 are related to the grade and poor prognosis of glioma. Enhancing the expression of FOXN2 and FOXF2 may provide a new idea for target therapy of glioma.

导出引用

张佳罗潇潇郭忻然吴锋郑兰荣. 胶质瘤中叉头框蛋白N2与F2的表达及意义[J]. 解剖学报. 2022, 53(2): 160-165 https://doi.org/10.16098/j.issn.0529-1356.2022.02.004

ZHANG Jia LUO Xiao-xiao GUO Xin-ran WU Feng ZHENG Lan-rong. Expression and significance of fork head box protein N2 and F2 in gliomas[J]. Acta Anatomica Sinica. 2022, 53(2): 160-165 https://doi.org/10.16098/j.issn.0529-1356.2022.02.004

中图分类号： R739.41

参考文献

［1］ Liu Y, Xu L. Research progress of miRNA in glioma ［J］.Chinese Journal of New Clinical Medicine, 2018,11(11):1163-1167.(in Chinese)

刘艳，许路. miRNA在神经胶质瘤中作用的研究进展［J］. 中国临床新医学，2018， 11(11)：1163-1167.

［2］ de Robles P, Fiest KM, Frolkis AD, et al. The worldwide incidence and prevalence of primary brain tumors: a systematic review and meta-analysis［J］. Neuro Oncol,2015,17(6):776-783.

［3］ Onishi M, Ichikawa T, Kurozumi K, et al. Angiogenesis and invasion in glioma［J］. Brain Tumor Pathol, 2011, 28(1):13-24.

［4］ Lefranc F, Brotchi J, Kiss R. Possible future issues in the treatment of glioblas tomas: special emphasis on cell migration and the resistance of migrating glioblastoma cells to apoptosis ［J］. Clin Oncol, 2005,23(10):2411-2422.

［5］ Jin Y, Liang ZQ, Lou HQ. The emerging roles of fox family transcription factors in chromosome replication, organization, and genome stability［J］. Cells, 2020, 9(1):258.

［6］ Ye H, Duan M. FOXN2 is downregulated in breast cancer and regulates migration, invasion, and epithelial-mesenchymal transition through regulation of SLUG ［J］. Cancer Manag Res, 2019,11(1):525-535.

［7］ He W, Kang Y, Zhu W, et al. FOXF2 acts as a crucial molecule in tumours and embryonic development［J］. Cell Death Dis, 2020,116(6):424-434.

［8］ Dou C, Jin X,Sun L, et al.FOXF2 deficiency promotes hepatocellular carcinoma metastasis by incliding mesenchymal-epithelial transition［J］. Cancer Biomark, 2017, 19(4):447-454.

［9］ Markouli M, Strepkos D, Papavassiliou KA, et al. Bivalent genes targeting of glioma heterogeneity and plasticity［J］. Int J Mol Sci, 2021,22(2):540-563

［10］ Li ChF, Jing W, Xiang DSh, et al. Expression of microRNA613 in human glioma and its effects on growth and metastasis［J］. Acta Anatomica Sinica，2018,49(5）:579-583. (in Chiese)

李传芬，荆文，向冬生，等. MicroRNA-613在人胶质瘤中的表达及其对增殖与转移的影响［J］.解剖学报，2018，49（5）：579-583.

［11］ Ramezani A, Nikravesh H, Faghihloo E. The roles of FOX proteins in virus-associated cancers ［J］.J Cell Physiol, 2019, 234(4):3361-3374.

［12］ Schuff M, Rossner A, Donow C, et al. Temporal and spatial expressionpatterns of FoxN genes in Xenopus laevis embryos［J］. Int J Dev Biol,2006,50(4):429-434.

［13］ Rho HK, McClay DR. The control of foxN2/3 expression in sea urchin embryos and its function in the skeletogenic gene regulatory network ［J］. Development,2011, 138(1):937-945.

［14］ Nagel S, Pommerenke C, Meyer C, et al. Identification of a tumor suppressor network in T-cell leukemia［J］. Leuk Lymphoma, 2017, 58(9):2196-2207.

［15］ Ma J, Lu Y, Zhang S, et al. β-Trcp ubiquitin ligase and RSK2 kinase-mediated degradation of FOXN2 promotes tumorigenesis and radioresistance in lung cancer［J］. Cell Death Differ, 2018,25(8):1473-1485.

［16］ Robertson E, Perry C, Doherty R, et al. Transcriptomic profiling of Forkhead box transcription factors in adult glioblastoma multiforme ［J］. Cancer Genomics Proteomics, 2015,12(3):103-112.

［17］ Zhang J, Zhang C, Sang L, et al. FOXF2 inhibits proliferation, migration, and invasion of Hela cells by regulating Wnt signaling pathway ［J］. Biosci Rep, 2018, 385(5):747-757.

［18］ Wang A, Jin C, Li H, et al. LncRNA ADAMTS9-AS2 regulates ovarian cancer progression by targeting miR-18-5p/FOXF2 signaling pathway［J］. Int J Biol Macromol, 2018,120(Pt B):1705-1713.

［19］ Higashimori A, Dong Y, Zhang Y, et al. Forkhead box F2 suppresses gastric cancer through a novel FOXF2-IRF2BPL-β-catenin signaling axis ［J］. Cancer Res, 2018, 787(7):1643-1656.

［20］ Wei WR, Zeng GJ, Liu C, et al. Overexpression of miR-96 promotes cell proliferati on by targeting FOXF2 in prostate cancer ［J］. Int J Clin Exp Pathol, 2017,107(7): 7596-7602.

［21］ Chen W, Tong K, Yu J. MicroRNA-130a is upregulated in colorectal cancer and promotes cell growth and motility by directly targeting forkhead box F2 ［J］. Mol Med Rep, 2017,164(4):5241-5248.

［22］ Zheng YZ, Wen J, Cao X, et al. Decreased mRNA expression of transcription factor forkhead box F2 is an indicator of poor prognosis in patients with resected esophageal squamous cell carcinoma ［J］. Mol Clin Oncol, 2015,33(3):713-719.

［23］ Yamashita H, Amponsa VO, Warrick JI, et al. On a FOX hunt: functions of FOX transcriptional regulators in bladder cancer［J］. Nat Rev Urol, 2017,142(2):98-106.

［24］ van den Brink GR, Rubin DC. Foxf2: a mesenchymal regulator of intestinal adenoma development ［J］. Gastroenterology, 2013,144(5):873-876.